Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis.

Idiopathic pulmonary fibrosis is a progressive and fatal fibrotic disease of the lungs with unclear etiology. Prior efforts to treat idiopathic pulmonary fibrosis that focused on anti-inflammatory therapy have not proven to be effective. Recent insight suggests that the pathogenesis is mediated through foci of dysregulated fibroblasts driven by profibrotic cytokine signaling. TGF-beta and PDGF are 2 of the most potent of these cytokines. In the current study, we investigated the role of TGF-beta-induced fibrosis mediated by activation of the Abelson (Abl) tyrosine kinase. Our data indicate that fibroblasts respond to TGF-beta by stimulating c-Abl kinase activity independently of Smad2/3 phosphorylation or PDGFR activation. Moreover, inhibition of c-Abl by imatinib prevented TGF-beta-induced ECM gene expression, morphologic transformation, and cell proliferation independently of any effect on Smad signaling. Further, using a mouse model of bleomycin-induced pulmonary fibrosis, we found a significant inhibition of lung fibrosis by imatinib. Thus, Abl family members represent common targets for the modulation of profibrotic cytokine signaling.

[1]  D. O'Leary,et al.  Modulation of the F-actin cytoskeleton by c-Abl tyrosine kinase in cell spreading and neurite extension , 2002, The Journal of cell biology.

[2]  A. Nicholson,et al.  The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. , 2002, American journal of respiratory and critical care medicine.

[3]  P. Opolon,et al.  Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene. , 1997, The Journal of clinical investigation.

[4]  A. Pendergast,et al.  The amphiphysin-like protein 1 (ALP1) interacts functionally with the cABL tyrosine kinase and may play a role in cytoskeletal regulation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Kopp,et al.  TGF-beta and fibrosis. , 1999, Microbes and infection.

[6]  D. Baltimore,et al.  Essential Roles for the Abl and Arg Tyrosine Kinases in Neurulation , 1998, Neuron.

[7]  David A. Lynch,et al.  Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .

[8]  W. Border,et al.  Transforming Growth Factor β in Tissue Fibrosis , 1994 .

[9]  V. Kaartinen,et al.  Abnormal lung development and cleft palate in mice lacking TGF–β3 indicates defects of epithelial–mesenchymal interaction , 1995, Nature Genetics.

[10]  D. Bissell.  Chronic liver injury, TGF-β, and cancer , 2001, Experimental & Molecular Medicine.

[11]  G. Laurent,et al.  Collagen production and replication by cardiac fibroblasts is enhanced in response to diverse classes of growth factors. , 1995, European journal of cell biology.

[12]  H. Beug,et al.  TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. , 1996, Genes & development.

[13]  D. Bissell.  Chronic liver injury, TGF-beta, and cancer. , 2001, Experimental & molecular medicine.

[14]  G. Daley,et al.  The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha. , 1999, Blood.

[15]  C. Joo,et al.  Involvement of Cell-Cell Interactions in the Rapid Stimulation of Cas Tyrosine Phosphorylation and Src Kinase Activity by Transforming Growth Factor-β1* , 2002, The Journal of Biological Chemistry.

[16]  K. Antman,et al.  Imatinib mesylate--a new oral targeted therapy. , 2002, The New England journal of medicine.

[17]  H. Moses,et al.  Interdependent SMAD and JNK Signaling in Transforming Growth Factor-β-mediated Transcription* , 1999, The Journal of Biological Chemistry.

[18]  A. Phillips,et al.  TGF-beta1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins. , 2003, Experimental cell research.

[19]  D. Morgan,et al.  Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats. , 1999, The American journal of pathology.

[20]  A. Pendergast.  The Abl family kinases: mechanisms of regulation and signaling. , 2002, Advances in cancer research.

[21]  R. A. Etten.  Cycling, stressed-out and nervous: cellular functions of c-Abl , 1999 .

[22]  A. Kazlauskas,et al.  c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. , 1999, Genes & development.

[23]  L. Wilming,et al.  A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the müllerian duct. , 1994, Development.

[24]  J. Lasky,et al.  Interstitial fibrosis and growth factors. , 2000, Environmental health perspectives.

[25]  Jeffrey B. Kopp,et al.  TGF- and fibrosis , 1999 .

[26]  S. Murphy,et al.  Cell-Type-Specific Activation of PAK2 by Transforming Growth Factor β Independent of Smad2 and Smad3 , 2003, Molecular and Cellular Biology.

[27]  A. Pardo,et al.  Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy , 2001, Annals of Internal Medicine.

[28]  M. Schmidt,et al.  Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. , 2001, American journal of respiratory and critical care medicine.

[29]  L. Wang,et al.  Distinct Role of Phosphatidylinositol 3-Kinase and Rho Family GTPases in Vav3-induced Cell Transformation, Cell Motility, and Morphological Changes* , 2002, The Journal of Biological Chemistry.

[30]  K P Offord,et al.  Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.

[31]  T. Colby,et al.  Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[32]  K. Csaky,et al.  Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. , 1997, The Journal of clinical investigation.

[33]  R. Pazdur,et al.  Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  S. Phan,et al.  Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. , 2001, Current pharmaceutical design.

[35]  Biao Hu,et al.  Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression. , 2003, American journal of respiratory cell and molecular biology.

[36]  K. O'Reilly,et al.  Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment. , 2001, Clinical immunology.

[37]  C. López-Otín,et al.  Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. , 2000, Journal of cell science.

[38]  W. Black,et al.  The epidemiology of interstitial lung diseases. , 1994, American journal of respiratory and critical care medicine.

[39]  P. Howe,et al.  TGF‐β induces fibronectin synthesis through a c‐Jun N‐terminal kinase‐dependent, Smad4‐independent pathway , 1999, The EMBO journal.

[40]  H. Lodish,et al.  Role of transforming growth factor beta in human disease. , 2000, The New England journal of medicine.

[41]  M. Refojo,et al.  Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. , 1999, Investigative ophthalmology & visual science.

[42]  D. Baltimore,et al.  The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization , 1989, Cell.

[43]  M. Selman,et al.  Idiopathic pulmonary fibrosis: new insights in its pathogenesis. , 2002, The international journal of biochemistry & cell biology.

[44]  K. Cutroneo,et al.  A molecular basis for bleomycin-induced pulmonary fibrosis. , 1986, Chest.

[45]  B. Mayer,et al.  Phosphorylation of c-Crk II on the Negative Regulatory Tyr222 Mediates Nerve Growth Factor-induced Cell Spreading and Morphogenesis* , 2000, The Journal of Biological Chemistry.

[46]  N. Kaminski,et al.  The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. , 1999, Cell.

[47]  P. Moseley,et al.  Augmentation of fibroblast proliferation by bleomycin. , 1986, The Journal of clinical investigation.

[48]  K. Miyazono,et al.  Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. , 1999, The Journal of clinical investigation.

[49]  J. Doré,et al.  Internalization-Dependent and -Independent Requirements for Transforming Growth Factor β Receptor Signaling via the Smad Pathway , 2002, Molecular and Cellular Biology.

[50]  N. Carragher,et al.  The Extracellular Matrix Dynamically Regulates Smooth Muscle Cell Responsiveness to PDGF a , 2000, Annals of the New York Academy of Sciences.

[51]  R. Goodman,et al.  Induction of lung fibrosis in the mouse by intratracheal instillation of fluorescein isothiocyanate is not T-cell-dependent. , 1999, The American journal of pathology.

[52]  R. Schilsky.  End points in cancer clinical trials and the drug approval process. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[53]  R. Strieter.  Mechanisms of pulmonary fibrosis: conference summary. , 2001, Chest.

[54]  J. Munger.  The integrin αvβ6 binds and activates latent TGFβ1 : A mechanism for regulating pulmonary inflammation and fibrosis , 1999 .

[55]  H. Moses,et al.  Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Arnold Simanowitz,et al.  international consensus statement , 2000 .

[57]  I. Adamson,et al.  The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. , 1974, The American journal of pathology.

[58]  Biao Hu,et al.  Smad3 Mediates Transforming Growth Factor-β–Induced α-Smooth Muscle Actin Expression , 2003 .

[59]  W. Border,et al.  Transforming growth factor beta in tissue fibrosis. , 1994, The New England journal of medicine.